DATE: December 5, 2018
TIME: 9:00AM PST
The mouse is a critical, increasingly used model system in biomedical research and preclinical drug discovery. While technological advances enable complex genetic manipulations that result in increased translational relevance, one distinct limitation remains - sample volume.
In addition, preclinical research increasingly demands measurement of multiple biomarkers (cytokines, chemokines, and growth factors) to characterize signaling pathways accurately or to analyze the effects of an intervention. Unfortunately, researches are often forced to design experiments around sample limitations.
The Bio-Plex® Multiplex System, powered by Luminex xMAP® Technology enables the quantification of more than 500 different protein or peptide targets simultaneously from a single sample volume. More specifically, the Bio-Plex Pro™ Mouse Cytokine, Chemokine, and Growth Factor Magnetic Bead-Based Assays detect and measure levels of 46 analytes in diverse matrices such as serum, plasma, and tissue culture supernatants.
This presentation will provide an overview of multiplexing technology for research use with mouse samples, and highlight the associated benefits to the drug discovery workflow.
- Reduced sample volume usage
- Enhanced dynamic range and quantitation in contrast to ELISA
- Global profiling and pathway analysis
- Increased throughput capabilities coupled with reduced cost and time inputs
- Superior data accuracy